Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Color additive fees

This article was originally published in The Tan Sheet

Executive Summary

Administration draft bill would charge $4.5 mil. in color and food additive registration fees in FY 2000, rising to $14.9 mil. in fiscal 2004. The FDA Review Fee Act would set color and food additive petition review fees at up to $260,000 per petition; by 2004, fees would increase to as much as $400,000 per petition. Fee amounts would depend on the petition category: a "Tier I" filing would be for approval of an additional use of an existing additive, while a "Tier III" filing would be necessary for a first-time approval that would result in "significant dietary exposure" or "raise novel safety issues," according to the draft document. Small businesses would be required to pay one-half the fee. The Administration is seeking a congressional sponsor. In the past, Congress has not favored additional user fees

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel